Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We maintain a Neutral recommendation on Pitney Bowes Inc ( PBI - Analyst Report ) . The company continued to make investments during 2011, as per its Strategic Transformation programs. However, the revenue for the year failed to show any growth, declining by 3% year over year and 6.5% for the fourth quarter.
Benefits from the Strategic Transformation programs were evident from EBIT improvement in four of the company’s seven business segments. Pitney’s equipment sales also improved in the first half of the year. However, continuing economic uncertainty remained a matter of concern, resulting in a few customers postponing their new equipment purchases and capital commitments during the second half of the year.
Pitney Bowes is a leading supplier of products and services in most of its business segments. Its meter base and its ability to place and finance meters in key markets contribute significantly to its revenue and profitability.
However, all segments face competition from a number of companies. We believe that its vast experience and reputation for product quality, as well as its sales and support service organizations, are important factors in influencing customer choices with respect to its products and services.
Significant investment in research and development operations differentiates Pitney Bowes from its competitors. The company has many research and development programs that are directed toward developing new products and service offerings.
As a result of these efforts, it has been awarded a number of patents for existing and planned products. However, its businesses do not depend on any one patent, any group of related patents, any one license or any group of related licenses.
The company continues to invest for future growth by delivering new products and solutions. Pitney Bowes continues with its phased launch of its innovative Connect+ mailing system and completed the acquisition of Portrait plc.
The company reported an outstanding free cash flow for the latest reported quarter of $215 million and generated $1.03 billion of free cash flow for the year. Driven by its sound cash structure, Pitney’s board of directors approved an increase in quarterly dividend for the 30th consecutive year.
However, most of its revenue is directly or indirectly subject to regulation and oversight by the USPS (United States Postal Service) and foreign postal authorities. It also depends on a healthy postal sector in its operating regions, which could be influenced positively or negatively by legislative or regulatory changes.
Its profitability and revenue in a particular country could be affected by adverse changes in postal regulations, the business processes and practices of individual posts, the decision of a post to enter into particular markets in direct competition, or the impact of any of these changes on postal competitors that do not use its products or services. An accelerated increase in the acceptance of electronic delivery technologies or other displacement of physical mail could adversely affect its business.
Pitney Bowes currently holds a Zacks Rank #3 which also implies short term Hold recommendation on the stock.
Read the full Analyst Report on PBI